Leucadia National Corporation »

Vaneck Vectors Pharmaceutical etf shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $351k 3.9k 90.36
2025-06-30 $287k 3.3k 87.96
2024-09-30 $317k 3.3k 95.03
2024-06-30 $270k 3.0k 91.48

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard World Inf Tech Etf (VGT)
Iren Ordinary Shares (IREN)
W.R. Berkley Corporation (WRB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Costco Wholesale Corporation (COST)
Eli Lilly & Co. (LLY)
Ishares Tr Russell 2000 Etf (IWM)
Pepsi (PEP)
Select Sector Spdr Tr Energy (XLE)
Cadence Design Systems (CDNS)
Chevron Corporation (CVX)
Citigroup Com New (C)
Nxp Semiconductors N V (NXPI)

View all positions for Leucadia National Corporation

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf